Andrew McGirty

Andrew McGirty joined our New Lawyers Group (NLG) in 2025. The NLG provides our newest lawyers with the opportunity to gain exposure to different practice areas and lawyering styles before making a commitment to a specific practice. Individuals in the NLG may focus on a particular area of practice, or compare practices, during their first year with Jones Day.

Andrew focuses on corporate and regulatory work within the Health Care & Life Sciences Practice. He assists with hospital system M&A transactions, affiliations, and joint ventures as well as all aspects of clinically integrated networks and accountable care organizations. In doing so, Andrew advises clients on intricate regulatory issues, including corporate practice of medicine, digital health, change of ownership requirements, the 340B Drug Pricing Program, tax exemption, and compliance with HIPAA, Stark Law, Anti-Kickback Statute, and Civil Monetary Penalties Law.

Andrew also has experience in emerging Center for Medicare and Medicaid Innovation Models, including the Advancing Chronic Care with Effective, Scalable Solution (ACCESS) Model, the Long-term Enhanced ACO Design (LEAD) Model, and the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot.